Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, made by Omega Pharma.1 The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.2
In the United Kingdom there are four different medicines using the Solpadeine name, with different active ingredients. The range includes:
- Solpadeine Headache, containing paracetamol with caffeine
- Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
- Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus)
- Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine
In 2016 it was one of the biggest selling branded over-the-counter medications in Great Britain, with sales of £43.1 million.3
In Australia it is marketed as Panadeine.4
References
References
- "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 14 September 2013.
- Corporate Comms (15 March 2012). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 14 September 2013.
- "A breakdown of the over-the-counter medicines market in Britain in 2016". Pharmaceutical Journal. 28 April 2017. Retrieved 18 March 2020.
- "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 17 November 2008. Retrieved 14 September 2013.